The Precision Peptide Company Inventory

The latest inventory for PNGAF is $360K as of July 2026. That compares with $96K in the prior-year period — up 278.6% year over year. Investors often review this figure alongside The Precision Peptide Company's historical trend and sector peers before judging valuation or financial health.

Over the past year, PNGAF's inventory moved from $96K to $360K — a 278.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in The Precision Peptide Company's operating scale or balance-sheet position.

A inventory figure of $360K for PNGAF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PNGAF's inventory ($360K), review year-over-year change from $96K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.